LMR Partners’s Integra LifeSciences IART Stock Holding History

LMR Partners’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,126	Closed	-$272K	–	400
2018 Q3	$272K	Sell	4,126 -78,208	-95%	-$4.86M	0.02%	266
2018 Q2	$5.3M	Buy	+82,334	New	+$5.1M	0.27%	84
2015 Q3	–	Sell	-35,826	Closed	-$987K	–	399
2015 Q2	$987K	Buy	+35,826	New	+$955K	0.12%	221

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LMR Partners's IART Position: Q4 2018 in Review

LMR Partners sold out of Integra LifeSciences (IART) in Q4 2018, closing a stake of 4,126 shares — an estimated $272K sold.

LMR Partners first reported a position in IART in Q2 2015 and held it in 3 quarters. The position peaked at $5.3M in Q2 2018. 248 funds tracked by Wall St. Rank hold IART as of Q4 2018.

LMR Partners reported no remaining Integra LifeSciences position as of Q4 2018 after selling out during the quarter.
LMR Partners sold 4,126 Integra LifeSciences shares in Q4 2018, an estimated $272K.
LMR Partners first reported a position in Integra LifeSciences in Q2 2015 and held it in 3 quarters.
LMR Partners's Integra LifeSciences position peaked at $5.3M in Q2 2018.
248 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2018.

Based on LMR Partners's 13F filing for Q4 2018, filed 14 Feb 2019.